C-LECTA
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, a genetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.
C-LECTA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2004-01-01
Address:
Leipzig, Sachsen, Germany
Country:
Germany
Website Url:
http://www.c-lecta.com
Total Employee:
101+
Status:
Active
Contact:
49-341-3552140
Email Addresses:
[email protected]
Total Funding:
1.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Apache Mobile Non Scaleable Content
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
EDUCELL
Educell operates in the fields of biotechnology, tissue engineering and cell biology.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Current Employees Featured
Founder
Investors List
Capricorn Partners
Capricorn Partners investment in Venture Round - c-LEcta
bm-t beteiligungsmanagement thuringen
bm-t beteiligungsmanagement thuringen investment in Venture Round - c-LEcta
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Venture Round - c-LEcta
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series C - c-LEcta
SHS Capital
SHS Capital investment in Series C - c-LEcta
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Venture Round - c-LEcta
Newest Events participated
Participated in Viral Safety 2017
on 2017-04-25 as exhibitor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as exhibitor
Official Site Inspections
http://www.c-lecta.com Semrush global rank: 5.61 M Semrush visits lastest month: 1.51 K
- Host name: 199.60.103.142
- IP address: 199.60.103.142
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "c-LEcta"
c-LEcta - Crunchbase Company Profile & Funding
C-LEcta may be growing as it has been acquired by Kerry, a world leader in taste and nutrition, which suggests a strategic expansion of Kerry's capabilities and potentially an increase in …See details»
About us | c-LEcta GmbH
C-LEcta is a global biotechnology company specializing in the development, production and distribution of enzyme products. The company uses world-class enzyme engineering and production technologies to provide its partners in the …See details»
Our team | c-LEcta GmbH
He is responsible for c-LEcta’s internal production facility as well as the manufacturing of c-LEcta’s products at external sites of contract manufacturing organizations. After graduating in …See details»
c-LEcta Company Profile 2024: Valuation, Investors, Acquisition
C-LEcta has raised $3.46M. Who are c-LEcta’s investors? Bader & Hirn Beteiligungs, Capricorn Partners , European Union Seventh Framework Programme, High-Tech Gründerfonds , and …See details»
c-LEcta GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for c-LEcta GmbH of Leipzig, Sachsen. Get the latest business insights from Dun & Bradstreet.See details»
c-LEcta Company Profile - Office Locations, Competitors ... - Craft
C-LEcta is a biotechnology company providing customized enzymes and microbial strains to industrial applications in regulated markets like pharma and food. The company covers the …See details»
About c-LEcta GmbH. - Ingredients Network
Aug 5, 2024 c-LEcta is part of the Kerry Group. Kerry is the world’s leading taste and nutrition partner for the food, beverage and pharmaceutical markets. The company employs 22,000 …See details»
c-LEcta - Ownership and Business Overview - Mergr
Feb 15, 2022 c-LEcta is a developer of enzymes and microbial strains for industrial biotech applications in food, feed, pharma, and chemistry; a self-developed technology platform for the …See details»
c-LEcta GmbH - Leadership Team - The Org
The Leadership Team at c-LEcta GmbH steers the company’s strategic direction and operational management. This team of senior executives is responsible for driving business growth, …See details»
C-Lecta - startbase.de
C-Lecta is a very big biotechnology company with a focus on enzyme engineering and application in regulated markets like the food and pharma industries. C-Lecta delivers cost-efficient and sustainable production processes which open new …See details»
c-LEcta - Funding, Financials, Valuation & Investors - Crunchbase
Their latest funding was raised on Aug 23, 2018 from a Venture - Series Unknown round. c-LEcta is funded by 5 investors. Capricorn Partners and bm-t beteiligungsmanagement thuringen are …See details»
Corporate mission | c-LEcta GmbH
C-LEcta into a recognized global leader for high-performance enzymes promoting human health. Corporate Mission. We are a highly respectful, diverse community driven primarily by a …See details»
c-LEcta - Contacts, Employees, Board Members, Advisors & Alumni
C-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets.See details»
c-LEcta GmbH, Financial Info, Board and Management, …
Changes In Board and Management in last 6 months: Men: 0 Women: 0 GENDER BALANCESee details»
c-Lecta - VentureRadar
C-LEcta is an industrial biotechnology company developing and implementing sustainable and economic industrial processes based on customized enzymes and microbial production …See details»
History | c-LEcta GmbH
2014: c-LEcta celebrates 10th birthday EBITDA break-even 2015: Over 1 million euros in revenue from products for the first time. 2012. New Headquarters . First prize winner of the John Sime …See details»
c-Lecta: from investment to exit | Capricorn Partners | Capricorn …
C-Lecta: from investment to exit c-Lecta is a global biotechnology company specializing in the development, production and distribution of enzyme products. The company uses world-class …See details»
Marc Struhalla - CEO and Managing Director @ c-LEcta
Marc is co-founder, shareholder and managing director of c-LEcta. He earned a Ph.D. at the University of Hamburg following an undergraduate study in biochemistry at the University of …See details»
c-LEcta - esgctcongress.com
Bc05b603-fb99-4485-8a7b-612395d439bb. c-LEcta is a world-leading biotechnology company with a focus on enzyme engineering and application in regulated markets like the pharma and …See details»